Stanford
Palo Alto, California, 94305, United States
NCT Number: NCT03970889
This study is examining whether the Klue app is effective in detecting missed or late meal boluses in patients with Type 1 diabetes. The app is programmed onto an Apple Watch and will detect potential missed boluses from hand motion. It will send text alerts to the user asking if they have bolused. This is a pilot study and will assess whether there is a change in the number of missed meal boluses in the two weeks prior to each visit. If the findings are significant, this software can be integrated in future closed-loop algorithms for automatic insulin delivery.
Looking for future studies?
Notify Me13 year and older
All sexes
Interventional
Not applicable
Palo Alto, California, 94305, United States
This will be a randomized, cross-over, unblinded study with subjects randomized upon entry into the study to either begin using the Klue software for 6 weeks or to continue with their usual care for 6 weeks. Subjects are eligible for enrollment if they are using a continuous glucose monitor (CGM) and insulin pumps or an insulin pen with memory and CGM, are missing or late in giving at least 4 food boluses in the previous two weeks, and they have an iPhone. Missing or late meal boluses will be assessed through their pump/pen and sensor downloads. This is a pilot study. The investigators do not have preliminary data to do a true power calculation. The primary outcome will be the change in the number of missed meal boluses in the two weeks prior to each visit. Secondary outcome measures will be the number of missed meal boluses in each month of the study, change in HbA1c levels (measured every 6 weeks), accuracy of the Klue software in detecting meals (true positive and false positive rates), and a user satisfaction survey.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Note: Adequately treated thyroid disease and celiac disease do not exclude subjects from enrollment. They may be participating in another trial, if this study is approved by the investigators of the other trial.
Klue is a software program the uses an Apple watch to detect hand motions which are indicative of eating.
Time frame: The two weeks prior to each study visit
A missed meal bolus is defined by no insulin dose within 2 hours from the start of the CGM rise.
Time frame: data for 1 month prior to each study visit at baseline, 6 weeks and 12 weeks of this 12 week study for each subject
sensor glucose values between 70-180 mg/dl
Time frame: All data for the 6 weeks on the Klue intervention arm when Klue is active
Percent of time a meal alert signaled a meal
Stanford University
Other
Pilot Study to Test Efficacy of Real-time Reminders on Apple Watch To Decrease Late or Missed Meal Boluses
Acronym: Klue
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03262415
Diabetes Mellitus, Diabetes Mellitus, Type 2
Boston, Massachusetts, United States
View Trial DetailsNCT03738852
Type1 Diabetes Mellitus
New Haven, Connecticut, United States
View Trial DetailsNCT03423589
Type1 Diabetes Mellitus, Type1diabetes
Milwaukee, Wisconsin, United States
View Trial DetailsNCT03588104
Behavior, Diabetes Mellitus
Leiden, South Holland, Netherlands
View Trial Details